Log in to save to my catalogue

Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage K...

Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage K...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1013527541

Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage Kidney Disease

About this item

Full title

Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage Kidney Disease

Publisher

Basel, Switzerland: S. Karger AG

Journal title

American journal of nephrology, 2012-01, Vol.35 (3), p.209-215

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Background: Matrix metalloproteinases (MMPs) play important roles in the pathophysiology of renal diseases, and imbalanced MMP-2 and its endogenous inhibitor (the tissue inhibitor of metalloproteinases-2; TIMP-2) are implicated in the vascular alterations of end-stage kidney disease (ESKD) patients. We have examined whether MMP-2 gene polymorphisms...

Alternative Titles

Full title

Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage Kidney Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1013527541

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1013527541

Other Identifiers

ISSN

0250-8095

E-ISSN

1421-9670

DOI

10.1159/000336108

How to access this item